The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.

NRx Pharmaceuticals shares jump 26.69% ahead of regulatory milestone update

Oct 30, 2026 06:21 (8h ago)

Verifying

NRx Pharmaceuticals said it will discuss a regulatory milestone for its Preservative-Free Ketamine program.
26.69%: NRXP shares reached $3.37 in Thursday after-hours trading.
The company scheduled an 8:30 a.m. ET Friday conference call before the market opened.